Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jane Armitage

Showing results (51-60 of 105) with videos related to

Pageof 11
Sort By:
Clinical Therapeutics|August 27, 2019
Serious Adverse Effects of Extended-release Niacin/Laropiprant: Results From the Heart Protection Study 2-Treatment of HDL to Reduce the Incidence of Vascular Events (HPS2-THRIVE) TrialRichard Haynes, Elsa Valdes-Marquez, Jemma C Hopewell, et al.
Circulation|April 28, 2012
Lipids and lipoproteins and risk of different vascular events in the MRC/BHF Heart Protection StudySarah Parish, Alison Offer, Robert Clarke, et al.
Circulation. Cardiovascular Quality and Outcomes|July 14, 2016
Effects of Vascular and Nonvascular Adverse Events and of Extended-Release Niacin With Laropiprant on Health and Healthcare CostsSeamus Kent, Richard Haynes, Jemma C Hopewell, et al.
Trials|December 7, 2019
Investigating modifications to participant information materials to improve recruitment into a large randomized trial, Richard Haynes, Fang Chen, et al.
The British Journal of Nutrition|June 1, 2025
Effect of supplementation with vitamin D on biochemical markers of iron status and erythropoiesis in older people: BEST-D trialAbigail A Lamikanra, Hoi Pat Tsang, Alireza Morovat, et al.
The Lancet. Haematology|August 7, 2019
Longer-term efficiency and safety of increasing the frequency of whole blood donation (INTERVAL): extension study of a randomised trial of 20 757 blood donorsStephen Kaptoge, Emanuele Di Angelantonio, Carmel Moore, et al.
Maturitas|February 28, 2015
Estimation of the optimum dose of vitamin D for disease prevention in older people: rationale, design and baseline characteristics of the BEST-D trialRobert Clarke, Connie Newman, Joseph Tomson, et al.
Archives of Disease in Childhood|October 7, 2020
Epidemiological surveillance study of female genital mutilation in the UKDeborah Hodes, Najette Ayadi O'Donnell, Karina Pall, et al.
European Heart Journal|April 8, 2022
Effects of aspirin on dementia and cognitive function in diabetic patients: the ASCEND trialSarah Parish, Marion Mafham, Alison Offer, et al.
Journal of the American Heart Association|October 26, 2017
Effects of Vitamin D on Blood Pressure, Arterial Stiffness, and Cardiac Function in Older People After 1 Year: BEST-D (Biochemical Efficacy and Safety Trial of Vitamin D)Joseph Tomson, Harold Hin, Jonathan Emberson, et al.
Pageof 11

Showing results (51-60 of 105) with videos related to

Sort By:
Pageof 11
Clinical Therapeutics|August 27, 2019
Serious Adverse Effects of Extended-release Niacin/Laropiprant: Results From the Heart Protection Study 2-Treatment of HDL to Reduce the Incidence of Vascular Events (HPS2-THRIVE) TrialRichard Haynes, Elsa Valdes-Marquez, Jemma C Hopewell, et al.
Circulation|April 28, 2012
Lipids and lipoproteins and risk of different vascular events in the MRC/BHF Heart Protection StudySarah Parish, Alison Offer, Robert Clarke, et al.
Circulation. Cardiovascular Quality and Outcomes|July 14, 2016
Effects of Vascular and Nonvascular Adverse Events and of Extended-Release Niacin With Laropiprant on Health and Healthcare CostsSeamus Kent, Richard Haynes, Jemma C Hopewell, et al.
Trials|December 7, 2019
Investigating modifications to participant information materials to improve recruitment into a large randomized trial, Richard Haynes, Fang Chen, et al.
The British Journal of Nutrition|June 1, 2025
Effect of supplementation with vitamin D on biochemical markers of iron status and erythropoiesis in older people: BEST-D trialAbigail A Lamikanra, Hoi Pat Tsang, Alireza Morovat, et al.
The Lancet. Haematology|August 7, 2019
Longer-term efficiency and safety of increasing the frequency of whole blood donation (INTERVAL): extension study of a randomised trial of 20 757 blood donorsStephen Kaptoge, Emanuele Di Angelantonio, Carmel Moore, et al.
Maturitas|February 28, 2015
Estimation of the optimum dose of vitamin D for disease prevention in older people: rationale, design and baseline characteristics of the BEST-D trialRobert Clarke, Connie Newman, Joseph Tomson, et al.
Archives of Disease in Childhood|October 7, 2020
Epidemiological surveillance study of female genital mutilation in the UKDeborah Hodes, Najette Ayadi O'Donnell, Karina Pall, et al.
European Heart Journal|April 8, 2022
Effects of aspirin on dementia and cognitive function in diabetic patients: the ASCEND trialSarah Parish, Marion Mafham, Alison Offer, et al.
Journal of the American Heart Association|October 26, 2017
Effects of Vitamin D on Blood Pressure, Arterial Stiffness, and Cardiac Function in Older People After 1 Year: BEST-D (Biochemical Efficacy and Safety Trial of Vitamin D)Joseph Tomson, Harold Hin, Jonathan Emberson, et al.
Pageof 11